WallStreetZenWallStreetZen

NASDAQ: ONCY
Oncolytics Biotech Inc Stock Ownership - Who owns Oncolytics Biotech?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oncolytics Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jared KellyChief Executive Officer2026-03-125,050$0.96
$4.85kBuy
James T. ParsonsDirector2026-03-1110,000$1.03
$10.30kBuy
Allison HagermanVP Product Development2026-02-1210,000$0.83
$8.30kBuy
Thomas Charles HeinemanChief Medical Officer2026-02-1212,132$0.83
$10.03kBuy
Jared KellyChief Executive Officer2026-02-1229,500$0.84
$24.84kBuy
Bernd R. SeizingerDirector2026-02-1240,000$0.85
$33.88kBuy
Deborah Margaret BrownDirector2026-02-1225,000$0.85
$21.25kBuy
Kirk LookChief Financial Officer2026-02-1212,000$0.84
$10.10kBuy
Wayne PisanoDirector2026-02-1230,000$0.85
$25.35kBuy
Patricia S. AndrewsDirector2026-02-1235,400$0.86
$30.30kBuy

1 of 2

ONCY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONCY insiders and whales buy or sell their stock.

ONCY Shareholders

What type of owners hold Oncolytics Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bernd R. Seizinger0.44%566,991$475.14kInsider
Wayne Pisano0.39%492,414$412.64kInsider
Kirk Look0.23%287,515$240.94kInsider
Thomas Charles Heineman0.22%282,818$237.00kInsider
Angela Holtham0.14%183,639$153.89kInsider
Allison Hagerman0.09%115,059$96.42kInsider
Jared Kelly0.09%114,050$95.57kInsider
Deborah Margaret Brown0.09%109,851$92.06kInsider
Patricia S. Andrews0.06%78,128$65.47kInsider
Andrew Aromando0.04%55,100$46.17kInsider

1 of 3

ONCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONCY0.00%1.86%Net Buying
SEER0.04%64.07%Net SellingNet Selling
PYPD0.02%0.02%
COYA0.03%9.20%
ANIX0.02%80.46%Net BuyingNet Buying
View Top Biotech Stocks

Oncolytics Biotech Stock Ownership FAQ

Who owns Oncolytics Biotech?

Oncolytics Biotech (NASDAQ: ONCY) is owned by 0.00% institutional shareholders, 1.86% Oncolytics Biotech insiders, and 98.14% retail investors. Bernd R. Seizinger is the largest individual Oncolytics Biotech shareholder, owning 566,991.00 shares representing 0.44% of the company. Bernd R. Seizinger's Oncolytics Biotech shares are currently valued at $476.27k.

If you're new to stock investing, here's how to buy Oncolytics Biotech stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.